Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

IMNN

Imunon (IMNN)

Imunon Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMNN
DateTimeSourceHeadlineSymbolCompany
28/09/202406:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:IMNNImunon Inc
27/09/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMNNImunon Inc
21/09/202406:05Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:IMNNImunon Inc
11/09/202406:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
11/09/202406:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
11/09/202406:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
11/09/202406:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
11/09/202406:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
11/09/202406:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
11/09/202406:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
10/09/202406:06GlobeNewswire Inc.UPDATE - IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive ManagementNASDAQ:IMNNImunon Inc
09/09/202422:30GlobeNewswire Inc.IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive ManagementNASDAQ:IMNNImunon Inc
03/09/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
03/09/202421:52Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMNNImunon Inc
29/08/202423:58Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:IMNNImunon Inc
29/08/202423:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IMNNImunon Inc
28/08/202422:30GlobeNewswire Inc.IMUNON to Host R&D Day on September 18thNASDAQ:IMNNImunon Inc
16/08/202422:57Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IMNNImunon Inc
16/08/202422:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
16/08/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
14/08/202423:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMNNImunon Inc
14/08/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
14/08/202422:00GlobeNewswire Inc.IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:IMNNImunon Inc
08/08/202407:04GlobeNewswire Inc.IMUNON to Hold Second Quarter 2024 Financial Results and Business Update Conference Call on Wednesday, August 14, 2024NASDAQ:IMNNImunon Inc
06/08/202401:53Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:IMNNImunon Inc
01/08/202422:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
01/08/202420:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMNNImunon Inc
31/07/202422:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
31/07/202422:00GlobeNewswire Inc.IMUNON Announces $10 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:IMNNImunon Inc
30/07/202422:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
 Showing the most relevant articles for your search:NASDAQ:IMNN